C6ORF170 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.45128353779E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.339095583892E-11 |
Normal-vs-Stage2 |
5.09609999754801E-08 |
Normal-vs-Stage3 |
4.89164264649844E-13 |
Normal-vs-Stage4 |
1.70408132049715E-12 |
Stage1-vs-Stage2 |
9.916400E-01 |
Stage1-vs-Stage3 |
1.073990E-01 |
Stage1-vs-Stage4 |
1.881780E-02 |
Stage2-vs-Stage3 |
3.311400E-01 |
Stage2-vs-Stage4 |
1.558630E-01 |
Stage3-vs-Stage4 |
4.965000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.67386113250723E-12 |
Normal-vs-AfricanAmerican |
2.97739999322033E-09 |
Normal-vs-Asian |
1.581350E-01 |
Caucasian-vs-AfricanAmerican |
7.149000E-01 |
Caucasian-vs-Asian |
6.233900E-02 |
AfricanAmerican-vs-Asian |
1.408170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.68685074189534E-12 |
Normal-vs-Female |
9.10571618106815E-12 |
Male-vs-Female |
5.303800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.1752000000097E-06 |
Normal-vs-Age(41-60Yrs) |
8.48020542676409E-11 |
Normal-vs-Age(61-80Yrs) |
1.84563475613686E-12 |
Normal-vs-Age(81-100Yrs) |
1.9831003505999E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.897800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.617000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.965000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.817900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.667500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.295600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.499900E-02 |
Normal-vs-Grade 2 |
3.09020031785678E-10 |
Normal-vs-Grade 3 |
1.67932334704801E-12 |
Normal-vs-Grade 4 |
1.64401825486493E-12 |
Grade 1-vs-Grade 2 |
1.057560E-01 |
Grade 1-vs-Grade 3 |
1.155260E-03 |
Grade 1-vs-Grade 4 |
7.016500E-04 |
Grade 2-vs-Grade 3 |
1.838840E-03 |
Grade 2-vs-Grade 4 |
9.000800E-04 |
Grade 3-vs-Grade 4 |
2.984000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.98599955661905E-10 |
Normal-vs-ccB subtype |
2.29805063867161E-12 |
ccA subtype-vs-ccB subtype |
1.456020E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.24099619469575E-11 |
Normal-vs-N1 |
1.364420E-04 |
N0-vs-N1 |
5.364600E-01 |
|
|